CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Duopharma Biotech Bhd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Duopharma Biotech Bhd
Lot 2599, Jalan Seruling 59, Kawasan 3,
Phone: +60 333232759p:+60 333232759 KLANG, 41200  Malaysia Ticker: DPHARMADPHARMA
Business Summary
Duopharma Biotech Berhad is a Malaysia-based pharmaceutical company. The Company is engaged in the manufacturing and distribution of pharmaceutical products. Its business segments include Consumer Healthcare (CHC), Ethical Classic Business (ECB) and Ethical Specialty Business (ESB). The CHC is engaged in the manufacturing, marketing and distribution of over-the-counter products, such as vitamins and supplements, analgesics, eyecare and antacids to the domestic, regional and international markets. Its CHC brands include Flavettes, CHAMPS, Uphamol and Eye Glo. The ECB comprises more than 300 generic drugs manufactured by the Company, such as Crystorvas, Prelica and Omesec, among others. The ESB is focused on drugs for targeted conditions, as well as medical devices and consumables. It has also diversified into the biosimilars space with technology and commercialization collaborations with international partners. ERYSAA, Basalog One and Zuhera are a few commercialized biosimilar brands.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Independent Non-Executive Chairman of the Board Siti SadiahBinti Sh Bakir 70 12/28/2017 4/5/2016
Chief Financial Officer Wu KongChek 57 7/1/2012 8/1/2000
Chief Executive Officer Duopharma Consumer Healthcare Sdn Bhd Shamsul IdhamBin A.iahad 50 1/1/2020 1/1/2020
11 additional Officers and Directors records available in full report.

Business Names
Business Name
CCM Duopharma Biotech Berhad
CCMDBIO
DPHARMA
Duopharma Biotech Berhad

General Information
Number of Employees: 1,512 (As of 12/31/2022)
Outstanding Shares: 961,942,451 (As of 12/31/2023)
Shareholders: 20,425
Stock Exchange: KUL
Fax Number: +60 333233923


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024